Association of Delivery System Integration and Outcomes for Major Cancer Surgery

Annals of Surgical Oncology
Jonathan LiChad Ellimoottil

Abstract

Integrated delivery systems (IDSs) are postulated to reduce spending and improve outcomes through successful coordination of care across multiple providers. Nonetheless, the actual impact of IDSs on outcomes for complex multidisciplinary care such as major cancer surgery is largely unknown. Using 2011-2013 Medicare data, this study identified patients who underwent surgical resection for prostate, bladder, esophageal, pancreatic, lung, liver, kidney, colorectal, or ovarian cancer. Rates of readmission, 30-day mortality, surgical complications, failure to rescue, and prolonged hospital stay for cancer surgery were compared between patients receiving care at IDS hospitals and those receiving care at non-IDS hospitals. Generalized estimating equations were used to adjust results by cancer type and patient- and hospital-level characteristics while accounting for clustering of patients within hospitals. The study identified 380,053 patients who underwent major resection of cancer, with 38% receiving care at an IDS. Outcomes did not differ between IDS and non-IDS hospitals regarding readmission and surgical complication rates, whereas only minor differences were observed for 30-day mortality (3.5% vs 3.2% for IDS; p < 0.001) and prol...Continue Reading

References

Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Apr 23, 1999·Medical Care·L I IezzoniK Miller
Nov 11, 2005·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Priscilla HollanderDavid J Ballard
Sep 27, 2006·Archives of Internal Medicine·Eric A ColemanSung-Joon Min
Dec 6, 2006·Annals of Internal Medicine·Ateev MehrotraMeredith B Rosenthal
Sep 8, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Charles D MahoneyCarole M Cotter
May 14, 2008·Health Affairs·Donald M BerwickJohn Whittington
Jan 8, 2010·Medical Care Research and Review : MCRR·Diane R RittenhouseJuned Siddique
May 5, 2010·Health Affairs·William B WeeksElliott S Fisher
Oct 18, 2011·Medical Care·Amir A GhaferiJustin B Dimick
Apr 19, 2012·JAMA : the Journal of the American Medical Association·Hung-Jui TanDavid C Miller
Sep 13, 2012·JAMA : the Journal of the American Medical Association·Donald M Berwick
Feb 22, 2013·JAMA Surgery·David C MillerJohn D Birkmeyer
Jun 20, 2013·JAMA Internal Medicine·J Michael McWilliamsBruce E Landon
Sep 21, 2013·The New England Journal of Medicine·Thomas C TsaiAshish K Jha
Dec 23, 2014·Health Services Research·Caroline S CarlinRoger Feldman
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kim F RhoadsLaura A Schmidt
Oct 27, 2015·Annals of Surgery·Kyle H SheetzAmir A Ghaferi
Feb 26, 2016·The New England Journal of Medicine·Rachael B ZuckermanArnold M Epstein
Mar 18, 2016·The New England Journal of Medicine·David J Shulkin
Apr 15, 2016·The New England Journal of Medicine·J Michael McWilliamsAaron L Schwartz
Oct 18, 2016·The Journal of Urology·Lindsey A HerrelBrent K Hollenbeck
Dec 14, 2016·The New England Journal of Medicine·J Michael McWilliams
Mar 25, 2017·Annals of Surgery·Matthew J ResnickDavid F Penson

❮ Previous
Next ❯

Citations

Jan 9, 2021·European Urology·Chanan ReitblatBoris Gershman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.